GlassScriptPhysician profile
Sonya Goodner
NPI 1487770939
$982.38
in general payments reported to CMS, 2019-2025
17 companies · $888 in 2025
The $888 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $94.12 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $245.77 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $157.23 | 2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $123.11 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $61.55 | 2025 | Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $53.95 | 2025 | Cobenfy |
| Supernus Pharmaceuticals, INC. | $46.05 | 2025 | Qelbree |
| Almatica Pharma LLC | $44.07 | 2024-2025 | Loreev Xr, Teriparatide |
| Tris Pharma INC | $37.70 | 2025 | Onyda Xr, Dyanavel Xr |
| Axsome Therapeutics, INC. | $32.77 | 2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.11 | 2025 | Caplyta |
| Emd Serono, INC. | $26.21 | 2024 | |
| Alkermes, INC. | $23.44 | 2025 | Lybalvi |
| Vanda Pharmaceuticals INC. | $22.07 | 2025 | Hetlioz, Fanapt |
| Lundbeck LLC | $21.21 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $20.55 | 2025 | Quviviq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $19.83 | 2024 | Azstarys |
| Indivior INC. | $17.76 | 2025 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Goodner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.